These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study. Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623 [TBL] [Abstract][Full Text] [Related]
4. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox. Tomita N; Terada-Hirashima J; Uemura Y; Shimizu Y; Iwasaki H; Yano R; Suzuki T; Saito S; Okumura N; Sugiura W; Ohmagari N; Ujiie M Hum Vaccin Immunother; 2023 Aug; 19(2):2242219. PubMed ID: 37559375 [TBL] [Abstract][Full Text] [Related]
5. Current Status of Vaccine Development for Monkeypox Virus. Rastogi A; Kumar M Adv Exp Med Biol; 2024; 1451():289-300. PubMed ID: 38801585 [TBL] [Abstract][Full Text] [Related]
6. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141 [TBL] [Abstract][Full Text] [Related]
8. Human monkeypox virus in the shadow of the COVID-19 pandemic. Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693 [TBL] [Abstract][Full Text] [Related]
9. An overview on mRNA-based vaccines to prevent monkeypox infection. Natami M; Gorgzadeh A; Gholipour A; Fatemi SN; Firouzeh N; Zokaei M; Mohammed Ali SH; Kheradjoo H; Sedighi S; Gholizadeh O; Kalavi S J Nanobiotechnology; 2024 Mar; 22(1):86. PubMed ID: 38429829 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis. Malone SM; Mitra AK; Onumah NA; Brown A; Jones LM; Tresvant D; Brown CS; Onyia AU; Iseguede FO Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833653 [TBL] [Abstract][Full Text] [Related]
11. Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein. Cai JP; Chu WM; Tam AR; Wang K; Han Y; Chen LL; Zhang X; Choi CY; Cheng VC; Chan KH; Chen Z; Hung IF; Fong CH; To KK Commun Med (Lond); 2023 Nov; 3(1):168. PubMed ID: 37993690 [TBL] [Abstract][Full Text] [Related]
12. The Current State and Progress of Mpox Vaccine Research. Wang X; Gu Z; Sheng S; Song R; Jin R China CDC Wkly; 2024 Feb; 6(7):118-125. PubMed ID: 38405601 [TBL] [Abstract][Full Text] [Related]
13. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents. Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948 [TBL] [Abstract][Full Text] [Related]
14. The assessment on cross immunity with smallpox virus and antiviral drug sensitivity of the isolated mpox virus strain WIBP-MPXV-001 in China. Zeng Y; Liu X; Li Y; Lu J; Wu Q; Dan D; Lv S; Xia F; Hu C; Li J; Zhang H; Du H; Jia R; Duan K; Wang Z; Li X; Yang X Emerg Microbes Infect; 2023 Dec; 12(1):2208682. PubMed ID: 37128898 [TBL] [Abstract][Full Text] [Related]
15. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406 [TBL] [Abstract][Full Text] [Related]
16. Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses. Rcheulishvili N; Mao J; Papukashvili D; Feng S; Liu C; Yang X; Lin J; He Y; Wang PG Viruses; 2023 May; 15(5):. PubMed ID: 37243206 [TBL] [Abstract][Full Text] [Related]
17. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Andrei G; Snoeck R Trends Pharmacol Sci; 2023 Oct; 44(10):719-739. PubMed ID: 37673695 [TBL] [Abstract][Full Text] [Related]